EMCURENSEOffline
EMCURE PHARMA · INE168P01015 · Small Cap · #271- Prev close
- 2,160.40
- Open
- —
- High
- —
- Low
- —
- Volume
- —
- Mkt cap (6-mo avg)
- ₹30,247 cr
Loading minute bars…
NSE 1-minute bars from our CandleApi gateway (history from 21 Jul 2026); longer timeframes are built from them. Prices not adjusted for corporate actions.
EMCURE is at its 52-week high, above its 200-day average, ahead of Healthcare by 13.5 pts over 3 months — a Small Cap company, #271 by market cap.NSE prices to 05 Nov 2026 · a description of the data, not advice
Overview
What the data says, line by line
A description, never a buy or sell word · tap a line for its detail
How big is it?
six-month average market cap
Our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page.
Did buyers take delivery?
latest session · 2026-11-05
Price & trend
Returns
to 05 Nov 2026
| Period | Stock | vs Nifty 500 | vs its industry |
|---|---|---|---|
| 1 week | +20.4% | +13.7 pts | — |
| 1 month | +16.8% | +11.6 pts | +12.4 pts |
| 3 months | +14.6% | +17.1 pts | +13.5 pts |
| 6 months | +35.3% | +34.7 pts | +22.0 pts |
| 1 year | +67.8% | +72.3 pts | — |
Industry: Healthcare (Nifty 500 classification) · rank 1 of 44 over 3 months. Points = the stock’s return minus the benchmark’s. Prices adjusted for splits and bonuses.
Averages & movement
Ownership
Who owns the company
% of all shares, by quarter
| Group | Dec 25 | Mar 26 | Jun 26 | Sep 26 |
|---|---|---|---|---|
| Promoters | 77.9% | 77.9% | 77.8% | 77.8% |
| FPI | 3.6% | 3.4% −0.2 | 4.9% +1.5 | 4.9% +0.1 |
| Mutual funds | 4.8% | 4.9% +0.1 | 6.9% +1.9 | 7.0% +0.2 |
| Other DII | 1.3% | 1.2% −0.1 | 1.6% +0.4 | 1.4% −0.1 |
| Individuals | 6.5% | 6.5% | 6.5% | 6.3% −0.1 |
| Others | 6.0% | 6.2% +0.2 | 2.4% −3.8 | 2.4% |
From the company’s quarterly shareholding pattern. Changes in percentage points against the quarter before. No quarters are on record between Sep 2022 and Jun 2025.
Promoter pledge
Sep 26
Holders
Sep 26
Indian passive funds’ stake
2026-06-30
2,04,688 shares held by Indian passive mutual-fund schemes. A floor, not the total — foreign ETFs, insurance and EPFO are not counted.
Which funds bought and sold
mutual funds · quarter ended 2026-06-30
| Fund | Shares | Change | Did |
|---|---|---|---|
| Aditya Birla SL Small Cap Fund(G)Active | +2,61,420 | +261.4% | bought |
| HSBC Small Cap Fund-Reg(G)Active | +2,09,580 | +31.0% | bought |
| Kotak Healthcare Fund-Reg(G)Active | +5,000 | +10.0% | bought |
| DSP Healthcare Fund-Reg(G)Active | −3,18,121 | −82.0% | sold |
| Aditya Birla SL Bal Bhavishya Yojna-Reg(G)Active | −32,296 | −29.4% | sold |
| Nippon India Multi Cap Fund(G)Active | −4,15,774 | −19.4% | sold |
Ranked by how much each fund changed its own position, not by size of trade. Every fund here still holds the company — one that sold out entirely leaves no record to find.
Mutual-fund schemes, month by month
fund houses’ own monthly portfolios
| Month | Schemes | Bought new | Added | Cut | Sold out | Shares held | Value |
|---|---|---|---|---|---|---|---|
| Sep 26 | 65 | 2 | 39 | 5 | 1 | −0.5% | ₹1,691 cr |
| Aug 26 | 64 | 4 | 32 | 4 | 1 | −2.0% | ₹1,624 cr |
| Jul 26 | 61 | 3 | 26 | 12 | 5 | −1.4% | ₹1,751 cr |
| Jun 26 | 63 | 6 | 26 | 16 | 2 | +0.7% | ₹1,662 cr |
| May 26 | 59 | 1 | 22 | 15 | 2 | +0.2% | ₹1,524 cr |
| Apr 26 | 60 | 4 | 30 | 6 | 6 | −1.2% | ₹1,507 cr |
Each month against the one before, counting only the fund houses that reported both (45 houses in Sep 26); a split or bonus is divided out first. “Partial” = fewer than five houses reported yet.
Fund ownership is a quarterly disclosure and counts Indian passive schemes only.
Results
Results
Events & filings
Disclosures & deals
last six months · NSE filings
- Board outcome03 Nov 2026
- Credit rating01 Sept 2026
- Board outcome06 Aug 2026
- Scheme / acquisition13 Jul 2026
- Scheme / acquisition03 Jul 2026
- Takeover (SAST)23 Jun 2026
- Bulk deal: SELL25 Jun 2026
- Bulk deal: SELL25 Jun 2026
- Block deal: BUY25 Jun 2026
- Block deal: BUY25 Jun 2026
Latest shown; 11 in six months on all disclosures.
EMCURE: only ratings, pledges, insider and takeover disclosures, buybacks, schemes, board outcomes and deals are listed. All deals.
Corporate actions
full published history
| Recent | Dividend | ₹3.6 | Final | 04 Sept 2026 | 04 Sept 2026 |
| Earlier | Dividend | ₹3 | Final | 14 Aug 2025 | 14 Aug 2025 |
2 shown. A falling price on an ex-date is not a loss: a dividend leaves the share as cash and a bonus multiplies the shares held.
Market capitalisation is our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page. Fund ownership is a quarterly disclosure and counts Indian passive schemes only. Nothing here is advice, a recommendation, or a view on the company.